Folate-Conjugated Rapamycin Slows Progression of Polycystic Kidney Disease
Authors:
Open Access
- 1 October 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 23 (10) , 1674-1681
Abstract
Activation of the mammalian target of rapamycin (mTOR) signaling pathway is aberrant in autosomal-dominant polycystic kidney disease (ADPKD). The mTOR inhibitors, such as rapamycin, ameliorate PKD in rodent models, but clinical trials have not shown benefit, possibly as a result of low tissue concentrations of rapamycin at clinically tolerable doses. To overcome this limitation, we synthesized a folate-conjugated form of rapamycin (FC-rapa) that is taken up by folate receptor–mediated endocytosis and cleaved intracellularly to reconstitute the active drug. We found that renal cyst-lining cells highly express the folate receptor in ADPKD and mouse models. In vitro, FC-rapa inhibited mTOR activity in a dose- and folate receptor–dependent manner. Treatment of a PKD mouse model with FC-rapa inhibited mTOR in the target tissue, strongly attenuated proliferation and growth of renal cysts and preserved renal function. Furthermore, FC-rapa inhibited mTOR activity in the kidney but not in other organs. In summary, these results suggest that targeting the kidney using FC-rapa may overcome the significant side effects and lack of renal efficacy observed in clinical trials with mTOR inhibitors in ADPKD.Keywords
This publication has 43 references indexed in Scilit:
- Signal transducer and activator of transcription-6 (STAT6) inhibition suppresses renal cyst growth in polycystic kidney diseaseProceedings of the National Academy of Sciences, 2011
- Polycystin-1 regulates STAT activity by a dual mechanismProceedings of the National Academy of Sciences, 2011
- Treatment of experimental adjuvant arthritis with a novel folate receptor-targeted folic acid-aminopterin conjugateArthritis Research & Therapy, 2011
- mTORC1-S6K Activation by Endotoxin Contributes to Cytokine Up-Regulation and Early Lethality in AnimalsPLOS ONE, 2010
- Molecular Advances in Autosomal Dominant Polycystic Kidney DiseaseAdvances in Chronic Kidney Disease, 2010
- Rapamycin fed late in life extends lifespan in genetically heterogeneous miceNature, 2009
- Long-term rapamycin therapy in the Han:SPRD rat model of polycystic kidney disease (PKD)Nephrology Dialysis Transplantation, 2009
- Polycystic Kidney DiseaseAnnual Review of Medicine, 2009
- Deficiency of FLCN in Mouse Kidney Led to Development of Polycystic Kidneys and Renal NeoplasiaPLOS ONE, 2008
- Kidney-Targeted Birt-Hogg-Dube Gene Inactivation in a Mouse Model: Erk1/2 and Akt-mTOR Activation, Cell Hyperproliferation, and Polycystic KidneysJNCI: Journal of the National Cancer Institute, 2008